1. MicroRNA-21 and the Vulnerability of Atherosclerotic Plaques
Temo Barwari, Marieke Rienks, Manuel Mayr 
Molecular Therapy 
Volume 26, Issue 4, Pages (April 2018)
DOI: /j.ymthe
Copyright © 2018 The American Society of Gene and Cell Therapy Terms and Conditions

2. Figure 1
MicroRNA-21-Based Therapy for Plaque Vulnerability and In-Stent Restenosis
Delivery of microRNA-21 (miR-21) mimic to atherosclerotic plaques by ultrasound-targeted microbubble destruction (UTMD) enhances smooth muscle cell proliferation while also steering monocytes toward a reparative, anti-inflammatory phenotype. Conversely, stents coated with miR-21 inhibitor (anti-miR-21) prevent in-stent restenosis through their anti-proliferative effect on smooth muscle cells.
Molecular Therapy  , DOI: ( /j.ymthe )
Copyright © 2018 The American Society of Gene and Cell Therapy Terms and Conditions